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i.e., in several serious diseases such as cancer, Alzheimer’s disease and aging, heart diseases and also
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60 I. Ali et al.complex structures and closely related physico-chemical behaviors. However, the recent advances in
liquid chromatography make this job easy. Various kinds of liquid chromatography, along with dif-
ferent detectors and optimization strategies, have been discussed in this article. Besides, attempts
have been made to include chirality concept in proteomics for understanding mechanism and med-
ication of various disease controlled by different body proteins.
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Each cell produces thousands proteins in living organisms and a
set of them is called as proteome and unlike genome, the prote-
ome differs from cell to cell (Garcia et al., 2004). After success of
human genome project, proteome is a new emerging ﬁeld of bio-
chemistry as it provides the knowledge of enzymes (proteins)
interactions with different body organs andmedicines, adminis-
trated into human body. Therefore, the study of proteomics is
very important for the development of new and effective drugs
to control many lethal diseases. In proteomics study, analyses
of proteome are very important and signiﬁcant from the patho-
logical point of views, i.e., in several serious diseases such as can-
cer (Le Naour et al., 2006; Vasilescu et al., 2005; Righetti et al.,
2005; Drew et al., 2005), Alzheimer’s disease and aging (Mon-
tine et al., 2006), heart diseases (Banﬁ et al., 2006) and plant biol-
ogy (Glinski and Weckwerth, 2006). The separation and
identiﬁcation of proteomics is a challenging job due to their
complex structures and closely related physico-chemical behav-
iors. However, literature indicated the successful use of liquid
chromatography in this concern. Most effectively used kinds
of chromatography are liquid chromatography–mass spectrom-
etry (LC–MS) (Neverova and Van Eyk, 2005; Hortin et al.,
2006), nano-reversed phase liquid chromatography (nano-
RPLC) (Wang et al., 2005; Tyan et al., 2006) and ion exchange
chromatography (Lecchi et al., 2003). Platelets, having no nu-
cleus in cells, are valuable to study hemostasis, thrombosis
and heart diseases. The proteins present in platelets have been
studied by multidimensional liquid chromatography followed
by mass spectrometry (Garcia et al., 2005). Over last few years,
the proteomic analysis reveals that it requires the combination
of on-line sample preparation and analytical methods due to
the diversity and complexity in proteomics structures. In view of
these facts, attempts have beenmade to review the role of liquid
chromatography in proteomics study. Various kinds of liquidchromatography, along with different detectors and optimiza-
tion, have been presented in this article.
1.1. Separation methods for proteins
Since the introduction of liquid chromatography in 1980 it has
become very popular in analytical science but its applications
came into practice in last decade. The nano detection makes
these chromatographic techniques more useful in proteomic
research. Various kinds of liquid chromatography methods
used in proteomic research are reversed phase, afﬁnity, gel per-
meation, ligand exchange and capillary liquid chromatogra-
phies, which are discussed in this article.
1.2. Reversed phase high performance liquid chromatography
Reversed phase high performance liquid chromatography is
the most popular mode of chromatography due to its wide
range of applications because of the availabilities of various
mobile and stationary phases. The on-line coupling of this
technique with sample preparation and detection units; spe-
cially MS; makes it ideal technique in proteomics research.
Nowadays, microchip based instruments are available to
achieve this difﬁcult task.
Some important separations of proteomics using RP-HPLC
are discussed and analyzed critically. Yuan and Zhao (2001)
reported that multidimensional liquid chromatography cou-
pled with tandem-mass spectrometry has wide range of appli-
cations in proteomics. Liang et al. (2006) quantiﬁed a group of
1600 gene products into 997 protein families with 830 mem-
brane or membrane-bound proteins in normal and malignant
breast cancer cells of a patient using nano-electrospray LC–
MS/MS method. Crugliano et al. (2007) applied liquid chro-
matography with tandem-mass spectrometry for the analysis
of proteome of transfected HeLA cell lines having three clear
Separation of biological proteins by liquid chromatography 61single amino acid changes in a nuclear phosphoprotein, i.e.,
BRCA1 protein. The authors reported that Met1775Arg and
the Trp1837Arg did not show effective changes in comparison
to cells transected having wild type BRCA1 cDNA and only
BRCA1-Ser1841 Asn mutation creates effective changes in
proteomic pattern in breast cancer patients. Sapra et al.
(2006) reported a nano-LC–MS method for the proteomic
analysis of two murine macrophages cell lines (J774.1A and
RAW 264.7), which were treated with Bacillus anthracis lethal
toxin (LeTx) in anthrax infection. The authors identiﬁed ﬁve
proteins as ATP synthase b-subunit, b-actin, Hsp 70, vimentin,
and Hsp60 homolog, which were unregulated in above cell
lines. Pan et al. (2006) performed a quantitative neuropeptido-
mic study for activity of prohormone convertase-2 (PC2) in
processing of hypothalamic neuropeptides and reported 53
neuropeptides or other peptides originating from 21 proteins
viz. proenkephalin, proopiomelanocortin, prodynorphin,
protachykinin A and B, procholecystokinin, promelanin-con-
centrating hormone, proneurotensin, proneuropeptide Y, pro-
vasopressin, pronociceptin/orphanin, prothyrotropin-releasing
hormone, cocaine, amphetamine-regulated transcript, chro-
mogranin A and B, secretogranin II, prohormone convertase
1 and 2, propeptidyl-amidating monooxygenase, proteins des-
ignated proSAAS and VGF; after labeling by isotopic tags in
extracts of mice with out PC2 and wild type young ones fol-
lowing fractionation with RP-HPLC column. Electrospray
ionization mass spectrometric method and tandem-mass spec-
trometry were used for analysis and identiﬁcation of above
said proteins, respectively.
An interaction between aquaporin and ﬁlaments was
reported using liquid chromatography (LC)–tandem-mass
spectrometry method. This interaction was supposed to be
responsible for the lens ﬁber cell shape (Lindsey Rose et al.,
2006). Andre et al. (2006) reported a LC–ESI-MS/MS and
MALDI-FTICR method for the identiﬁcation of tetraspanin,
which were integral membrane proteins, in a model of human
colon cancer. These identiﬁed proteins were integrins, Lu/B-
CAM, GA733, BAI2, PKC, G, proteages (ADAM10,
TADG15) and syntaxins proteins. Rosas-Acosta et al. (2005)
reported SUMO-1 and SUMO-3 as stable modiﬁed proteins
having half lives more than 20 h by LC–MS. Shin et al.
(2004) described 12 proteins out of 37 different proteins related
with Alzheimer’s disease in the cortex of Tg2576 mice using
matrix-assisted laser desorption/ionization-time-of ﬂight
(MALDI-TOF) and liquid chromatography–tandem-mass
spectrometry. The whole phosphoproteome was studied using
multidimensional liquid chromatography with electrospray
mass spectrometric method in eukaryotic living beings
(Metodiev et al., 2004). Soreghan et al. (2003) reported a liquid
chromatography and tandem-mass spectrometry method to
identify the carbolylated proteins in aged mouse brain homog-
enates. Brock et al. (2003) identiﬁed K7, K37 and K41 as main
sites of glycation and carboxymethylation of RNase by using
electrospray ionization liquid chromatography–mass spec-
trometry (ESI-LC–MS) method after the incubation of RNase
(13.7 mg/mL, 1 mM) with glucose of 0.4 M concentration at
37 C for a period of 14 days in phosphate buffer. The average
value of mass measurement accuracy (MMA) of apomyoglo-
bin was reported by using nano-liquid chromatography-dual
electrospray ionization-Fourier transform-ion cyclotron reso-
nance-mass spectrometry (nano-LC-dual ESI-FT-ICR-MS)
as 1.09 versus 74.5 ppm (Nepomuceno et al., 2003).Babusiak et al. (2007) reported 55 proteins including pepti-
dase, ion channels, cycloskeletal proteins, enzymes of carbohy-
drate metabolism, regulatory enzymes etc. using PepMapTM
C18 column (0.3 mm · 250 mm). Various proteins identiﬁed
by LC MS/MS. Carlsohn et al. (2006) performed a nano-liquid
chromatography Fourier transform-ion cyclotron response
mass spectrometry (nano-LC FT-ICR MS) analysis of the out-
er membrane protein of Helicobacter pylori, a human gastric
pathogen which can create duodenal ulcers, gastric cancer dis-
eases, using (17 cm · 50 lm i.d.) fused silica column packed
with 3 lm ReproSil-Pur C18-AQ porous C18-bonded particles
and identiﬁed 60 membrane associated proteins including (out-
er membrane protein) Omp11 and BabA proteins in each
strain. The authors reported that the fragmentation efﬁciency
in the ion trap of the nano-LC FT-ICR MS and MS/MS anal-
ysis are more reproducible; Fig. 1. Seshi (2006) reported that
80 of 712 proteins in mesenchymal progenitor cell proteome
create 5258 of 10506 detected peptides. Few represented
mesenchymal progenitor cell (MPC) proteins create a large
number of MPC peptides, which are shown in Fig. 2. A com-
parative study of peptides of different Caenorhabditis elegans
strains, a nematode species, was performed using 0.1% triﬂu-
oroacetic acid (TFA) with 50% acetonitrile (CH3CN) on
symmetry (4.6 mm, i.d. · 250 mm) C18 column for HPLC
analysis followed by matrix-assisted laser desorption ioniza-
tion-time-of-ﬂight mass spectrometry (MALDI-TOF). Fur-
thermore, 2–50% acetonitrile and 0.1% formic acid; in the
same column; with a ﬂow rate of 200 nL/min is used for
on-line nano-liquid chromatography-quadrupole time-of-ﬂight
tandem-mass spectrometry (nano-LC-Q-TOF-MS/MS) to
conﬁrm the sequence of several naturally occurring peptides
as shown in Fig. 3 (Husson et al., 2006). The authors reported
that the presence of FMRFamide-like peptide (FLP) and neu-
ropeptide like protein (NLP) in wild type strain of C. elegans
was due to the activity of EGL-3 gene.
Gallagher et al. (2006) achieved the isolation of glutathione
S-transferase isoenzyme (GSTs), for the detoxiﬁcation of xeno-
biotics and endogenous toxicants, using a (150 mm · 4.6 mm)
Vydac 214TP C4 column with 37% acetonitrile having
0.075% triﬂuoroacetic acid (TFA) in water using HPLC sub-
unit analysis of glutathione (GSH) afﬁnity-puriﬁed human li-
ver mitochondrial proteins. The authors identiﬁed three
human liver mitochondrial GST isoenzymes namely hGSTA1
and hGSTA2 of alpha class GST and hGSTP1 of pi class
GST subunits. The authors reported three GSH afﬁnity-puri-
ﬁed human liver mitochondrial proteins at 14.7, 19.2 and
21.5 min retention times.
Vanrobaeys et al. (2005) analyzed the peptide mixture by
combination of MALDI MS/MS with off-line liquid chroma-
tography and recognized 377 unique peptides with the identiﬁ-
cation of 93 proteins. Wang et al. (2005) reported nano-RPLC
as an important method for single and multidimensional pro-
tein separation of complex protein mixtures before mass spec-
trometric analysis. The authors also reported the effects of
various chromatographic conditions on protein separation
such as alkyl chain length in the stationary phase, temperature
and ion pairing agent including C18 column at 60 C with TFA
instead of heptaﬂuorobutyric acid (HFBA). The inﬂuence of
alkyl chain length in stationary phase for model protein sepa-
ration is shown in Fig. 4 at 25 C column temperature using
acetonitrile as mobile phase having 0.1% TFA. Zolla et al.
(2003) identiﬁed the photosystem II (PS II) antenna proteins
Figure 2 Few represented MPC proteins create a large no of MPC peptides Seshi (2006).
Figure 1 Analysis of a tryptic digest of a protein band from an Outer membrane protein (Omp) at two various times. (A) In LC
separation, chromatogram represents the high reproducibility of the retention time and peak distribution (B) the measurements of mass of
peptides with doubly protonated at m/z 836.94 at 21.32 and 21.25 min. (C) CID spectra of doubly protonated peptide showed at m/z
836.94 Carlsohn et al. (2006).
62 I. Ali et al.on Vydac protein C4 column with 27.5–63.5% acetonitrile,
0.05% triﬂuoroacetic acid in water as mobile phase with
1.0 mL/min. ﬂow rate with MS detection in arabidopsis, pea
and tomato. Fig. 5 represents the ion chromatogram of pea
with protein components of PS II. Reh et al. (2006) reported
that neither surface area nor pore diameter played an impor-
tant role in the application of reversed phase for HPLC for
proteomics.
Monti et al. (2005) identiﬁed various proteins by FASTA
and protein Prospector software in tryptic peptide mixture ofﬁsh from sea and farm by LC-ES/MS/MS study using a nar-
row-bore Phenomenex Jupiter C18 column (250 · 2.1 nm) with
0.05% (v/v) TFA, 5% (v/v) formic acid in H2O and 0.05% (v/
v) TFA, 5% (v/v) formic acid in acetonitrile as solvent. Chen
et al. (2005) reported a 2D-LC–MS/MS method to identify
secretory proteins from rat adipose cells. The authors sepa-
rated these proteins using Zorbax 300 SB-C3 reversed phase
column (150 mm · 4.6 mm) with ﬂow rate of 700 lL/min of
TFA and acetonitrile. The authors separated 33 protein com-
plexes; called as bands; by two-dimensional LC–MS/MS using
Figure 3 Comparative study of MALDI-TOF MS spectra (a): C18 HPLC analysis of wild type C. elegans extract and obtained fractions
were further analyzed by MALDI-TOF MS (only fraction 35 is shown in ﬁgure). Measured masses were compared with theoretical masses
of FLP and NLP peptides. (b) The analysis of extracts of various C. elegans strains with mutated egl-3 with same procedure as with wild
type strains. Zoom spectrum of fraction 35 of 4 strains namely n588, n150, n729 and gk238 are shown Husson et al. (2006).
Separation of biological proteins by liquid chromatography 63a Mono Q HR 5/5 column with sodium chloride from 0.1 M
NaCl in murine erythroleukemic cells.
A nano-HPLC-MS/MS method for the study of low abun-
dance proteins in silico analysis of complex protein samples
was reported using 5 lm Zorbax SB C18 using buffer A:
95% H2O, 5% acetonitrile, 0.1% formic acid and buffer B:
90% acetonitrile, 10% water, 0.025% triﬂuoroacetic acid and
0.1% formic acid (Bihan et al., 2004). Garcia et al. (2005) used
a nano-ﬂow high performance liquid chromatographic
(HPLC) method using 0.1% acetic acid as solvent A and
70% acetonitrile in 0.1% acetic acid as solvent B with the
detection by mass spectrometer. Elortza et al. (2006) identiﬁed11 human glycosylphosphadylinositol anchored proteins (GPI-
APs) and 35 Arabidopsis thaliana GPI-APs using a 2 cm fused
silica Zorbax SB-C18 column with solution A having acetoni-
trile in 1% formic acid/0.6% acetic acid/0.005% heptaﬂuo-
robutyric acid (HFBA) with 40% B solution containing 90%
acetonitrile in 1% formic acid/0.6% acetic acid/0.005% HFBA
as mobile phases for half an hour. Hoffert and coworkers
(Hoffert et al., 2007) performed LC–MS/MS phosphoproteo-
mic analysis of phosphopeptides obtained from membrane
fractions of rat kidney inner medullary collecting duct (IMCD)
on a C18 pre-column for desalting the digested peptide mixture
and these peptides were subjected to a Picofrit reverse-phase
Figure 4 Comparative study of model protein separation by
using (A): C4 column (B): C18 at 25 C with an elution order as (1)
ribonuclease A, (2) cytochrome c (3) bovine serum albumin and (4)
myoglobin using acetonitrile as mobile phase having 0.1% TFA
with 200 nL/min ﬂow rate Wang et al. (2005).
64 I. Ali et al.analytical column which has the elution of these peptides with
0–60% acetonitrile in 0.1% formic acid maintaining 250 nL/
min ﬂow rate. Fourier transform mass spectrometer having a
nanospray ion source was used to analyze the peptides. The
authors reported CIC-1, LAT4, MCT2, NBC3 and NHE 1
as solute transporter proteins having new phosphorylation
sites. Calvete et al. (2007) determined the compositions of
the venoms of snakes such as Bitis gabonica rhinoceros (West
African gaboon viper), Bitis nasicornis (Rhinoceros viper), Bi-
tis caudalis (Horned puff adder) using RP-HPLC followed by
N-terminal sequencing, MALDI-TOF peptide mass ﬁnger-
printing and CID-MS/MS methods. For this RP-HPLC sepa-
ration, the authors used a Lichrosphere RP100 C18 column
(25 cm · 4 mm, i.d.) with 0.1% triﬂuoroacetic acid (TFA) in
water as solution A and acetonitrile with different concentra-
tion for different times as solution B. Table 1 presents proteins
of total HPLC-analyzed in venom of various snake species. Li
et al. (2007) reported iTRAQ reagents tagging in conjugation
with LC–LC MS/MS analytical study advantageous for quan-
titative study of synaptic proteomes of wild type mice and
30UTR-calcium/calmodulin-dependent kinase II a mutant
mice. The authors used 300 lL of buffer having 20% acetoni-
trile, 10 mM KH2PO4 with 2.9 pH to dissolve dried iTRAQ-
tagged sample and injected into a Polysulfoethyl A column.
The column used was of 150 mm · 100 lm i.d. with a
500 nL/min ﬂow rate of mobile phase.
1.3. Afﬁnity high performance liquid chromatography
Afﬁnity HPLC is a chromatographic method capable to sepa-
rate biochemical mixtures of highly speciﬁc nature. It is possi-ble to design a stationary phase that reversibly binds to a
known subset of molecules just by combining afﬁnity chroma-
tography. This kind exploits a well known and deﬁned prop-
erty of analytes which can be used during puriﬁcation
process. The process can be considered as an entrapment with
the target molecule trapped on a stationary phase while the
other molecules in solution did not trap due to lack of this
property.
Tumor necrosis factor receptor, i.e., factor 6 (TRAF6)
binding proteins, having many heat shock proteins, in osteo-
clast cells were reported by Ryu et al. (2005) using afﬁnity
chromatography followed by mass spectrometric technique.
Matsumoto et al. (2005) studied ubiquitin-conjugated and
ubiquitin-associated proteins in human cells by immunoafﬁn-
ity chromatography and LC–MS/MS. The authors reported
345 proteins as ubiquitin-related proteome in denaturing
conditions (Urp-D) and 325 proteins as ubiquitin-related
proteome in native conditions (Urp-N). Welch et al. (2005)
studied many potential susceptibility factors, which were oc-
curred in the livers of SJL mice using a C18 pre-column
(100 lm · 2 cm) followed by 5% solvent B (100% acetoni-
trile) for loading of isotope-coded afﬁnity tag (ICAT)-
labeled puriﬁed peptide strong cation exchange (SCX) frac-
tions. Furthermore, the authors reported the separation of
these peptides using a (75 lm · 15 cm) self packed Magic
C18 AQ column with 250 nL/min ﬂow rate of 99.9% H2O
in 0.1% HCOOH (solvent A) and 100% acetonitrile (solvent
B). Mass spectrometric analytical study has been done and
studied the correlation between experimental data with the-
oretical spectra using a SEQUEST program. Senis et al.
(2007) reported liquid chromatography and tandem-mass
spectrometry, lectin afﬁnity chromatography, biotin/NeutrA-
vidin chromatography for the analysis of transmembrane
proteins in human platelets and mouse mega-karyocytes.
The authors reported unique peptides for 46, 68 and 22 sur-
face membrane and intracellular membrane, respectively,
and identiﬁed new plasma membrane proteins covering
immunoglobulin member G6b-B, a immunoreceptor tyro-
sine-based inhibition motif.
Immobilized metal afﬁnity chromatography was used for
the puriﬁcation of phosphopeptides from Arabidopsis root cell
culture and reported 79 phosphorylation sites in 22 phospho-
proteins having a central role in RNA metabolism using Pep-
Map C18 (300 lm · 5 mm), column and 0.1% TFA with
20 lL/min. ﬂow rate in a nano-HPLC technique (de la Fuente
van Bentem et al., 2006). Cantin et al. (2006) reported up reg-
ulation of 106 phosphopeptides and 145 phosphorylation sites.
Afﬁnity chromatography was reported as an indispensable
tool for the separation of complex proteins (Azarkan et al.,
2007). Cao and Stults (2000) used immobilized metal afﬁnity
chromatography coupled with electrospray ionization tandem
MS and Stensballe et al. (2001) described same techniques with
matrix-assisted laser desorption/ionization (MALDI) MS in
phosphoproteomic analysis.
1.4. Gel permeation high performance liquid chromatography
Basically, Gel Permeation High Performance Liquid Chroma-
tography works on the principle of sizes of the compounds and
in this big size molecules eluted ﬁrst followed by small size
molecules. It involves the transport of a liquid mobile phase
Figure 5 Identiﬁcation of protein components of photosystem II by using reversed-phase HPLC-ESI-MS Zolla et al. (2003).
Separation of biological proteins by liquid chromatography 65through a column containing a porous material as stationary
phase. It also called as size-exclusion chromatography and af-
fords a rapid method for the separation of polymeric species.
Therefore, it is a method of choice for separation of biomole-
cules such as peptides, proteins, enzymes. The stationary phase
is porous solid such as glass or silica, or a cross-linked gel
which contains pores of appropriate dimensions to effect the
separation desired. Tran et al. (2004) reported the separation
and isolation of proteins from rat liver nuclei by using micro-
cystin-Sepharose chromatography followed by mass spectrom-
etry. The authors also identiﬁed two novel peroxisomal
proteins, one was peroxisome-speciﬁc isoform of Lon protease
and the other was made up of an aminoglycoside phospho-
transferase-domain with an acyl-CoA dehydrogenase domain
(Kikuchi et al., 2004).1.5. Ligand exchange high performance liquid chromatography
Ligand exchange-HPLC is the advance version of RP-HPLC
where the reversed phase column is replaced by ion exchange
column. It has been used widely for the analysis of all inor-
ganic and organic ionic species. In LE-HPLC, anion and cat-
ion exchange columns are used but, nowadays, mixed (anion
and cation) columns are also available which improve the sep-
aration efﬁciency. In cation exchange chromatography, the
stationary phase is usually composed of resins containing sul-
fonic acid groups or carboxylic acid groups of negative charges
and, thus, cation metallic species are attracted to the stationary
phase by electrostatic interactions. In anion exchange chroma-
tography, the stationary phase is a resin, generally, containing
primary or quaternary amine functional groups of positive
Table 1 Percentage of proteins reported in venoms of various families of snakes by HPLC separation Calvete et al. (2007).
% of total venom proteins
Protein family B. g. rhinoceros B. nasicornis B. g. gabonica B. a. arietans B. caudalis
Bradykinin-potentiating peptides
Dimeric disintegrin 0.3 – 2.8 – –
Long disintegrin 8.5 3.5 3.4 – 2.3
Kunitz-type inhibitors – – – 17.8 –
Cystatin 7.5 – 3.0 4.2 3.2
DC-fragment 5.3 4.2 9.8 1.7 –
svVEGF 0.6 <0.1 0.5 – –
PLA2 – – 1.0 – –
Serine proteinase 4.8 20.1 11.4 4.3 59.8
CRISP 23.9 21.9 26.4 19.5 15.1
C-type lectin 1.2 1.3 2.0 – 1.2
L-amino acid oxidase 14.1 4.2 14.3 13.2 4.9
Zn2+-metalloproteinase 2.2 3.2 1.3 – 1.7
Unknown peptides 30.8 40.9 22.9 38.5 11.5
0.8 0.7 1.2 0.9 0.3
Figure 6 Separated quantity of proteins from C. glutamicum membranes by washing with different solutions Schluesener et al. (2005).
66 I. Ali et al.charge and, thus, these stationary phase groups pull solutes of
negative charge. It can be used effectively for the speciation of
cationic, anionic and neutral species simultaneously.
Schluesener et al. (2007) reported anion exchange chroma-
tography using an anion exchange column as faster and more
effective technique for the separation and quantiﬁcation of
membrane proteins of wild type Corynebacterium glutamicum
and L-lysine producing strain. They also identiﬁed the proteins
in the membrane of either wild type or the L-lysine. Further-
more, Schluesener et al. (2005) presented a signiﬁcant method
for the analysis of membrane proteome of a gram positive bac-
teria, i.e., C. glutamicum using a column (10 cm · 4.6 mm i.d.)
in ion exchange chromatography. Quantities of proteins were
separated from C. glutamicum membranes using different
washing solutions as given in Fig. 6. The authors reported
2.5 M NaBr as the best washing solution; among various lower
concentration solutions of NaBr because it removes 40% ofproteins. The neutral buffer (Tris–HCl, pH 8.0) or sodium car-
bonate (pH 11) separated 18% and 26% of total protein from
membranes, respectively, while 6 M urea solution separated
70% and 4 M guanidine thiocyanate separated approximately
90% of the total protein from the membranes. Metz and
coworkers (Metz et al., 2006) characterized isolated human
pancreatic islet proteomes and identiﬁed 29,021 peptides
equivalent with 3365 proteins using two-dimensional liquid
chromatography (2D-LC) followed by ion-trap tandem-mass
spectrometric (MS) study. Strong cation exchange (SCX)
fractionations of enzymatic digests of proteins from human
pancreatic islet have been carried out on a Polysulfoethyl A
(200 · 2.1 mm) column with 10 mM ammonium formate in
water having 25% acetonitrile and 500 mM ammonium for-
mate in water having 25% acetonitrile in SCX chromatogra-
phy with a ﬂow rate of 0.2 mL/min. The protein was
extracted by using urea/CHAPs or TFE.
Separation of biological proteins by liquid chromatography 67Opiteck et al. (1997, 1998) performed proteomic analysis of
fractions of Escherichia coli lysates using combination of
strong cation-exchange (SCX) or size-exclusion chromatogra-
phy (SEC) coupled with RP-HPLC followed by UV and mass
spectrometry detection. Wagner and coworkers (Wagner et al.,
2002) reported a fast multidimensional chromatographic
method as the combination of ﬁrst-dimension ion-exchange
chromatography with four reversed phase columns for the
analysis of small protein and peptides of human haemoﬁltrate.
A three-dimensional peptide fractionation approach for the
quantitative proteomic study is reported (Link, 2002) in which
trypsin digested and isotope-coded afﬁnity tag (ICATTM) re-
agent of a complete proteome lysate is fractionated. Lecchi
et al. (2003) performed a multidimensional chromatographic
separation using size-exclusion chromatography for the pro-
teomic analysis of E. coli (Strain BL 21). The authors used a
TSKG3000SWxL 7 · 300 mm column and KH2PO4 50 mM
and NaCl 200 mM in water as mobile phase for some aliquotsTable 2 HPLC identiﬁed proteins from BT474 and MCF7 cell mem
BT474 % of total MCF
Protein locations 602 313
Mitochondrion 15 2.5 4
Plasma membrane 49 8.1 24
Peroxisome 3 0.5 2
Nucleus 45 7.5 27
Endoplasmic reticulum 22 3.7 9
Cytoplasm 35 5.8 27
Golgi apparatus 2 0.3 1
Proteasome 4 0.7 1
Ribosome 22 3.7 22
Unknowns 392 65.1 195
Location unclear 15 2.5 1
604a 100.00 313
a 2 reported at multiple locations.
Figure 7 A view on 2D-nano-LC–MS/MS analysis. (A) Total ion cur
extract after 2D-nano LC separation. (B) The ion at m/z 504.34 is
GSLSNMMRI amide sequence of fragmentation spectra of selected pand other aliquots by reversed phase C18, (4.6 mm,
i.d. · 150 mm) column (218 TP 5415 Vydac) with linear gradi-
ent of acetonitrile and water having 0.1% TFA as mobile
phase for two-dimensional separation study in SEC. The
authors reported that liquid-based isoelectrofocusing-size-
exclusion chromatography (IEF-SEC) was able to separate
milligrams of proteins according to isoelectric point and
molecular size. Xiang et al. (2004) reported a liquid chromato-
graphic study of membrane proteins obtained from breast can-
cer MCF7 and BT474 cells using a fused silica strong cation
exchange (SCX) column of (7.5 cm · 75 lm i.d.) having Poly-
sulforthyl A resin. The authors identiﬁed total 313 proteins
from MCF7 cell membranes, 602 proteins from BT474 cell
membranes and 117 common proteins in MCF7 and BT474
cell membranes as given in Table 2. Fung et al. (2004) stud-
ied lacrimal-speciﬁc praline-rich proteins having signiﬁcant
role in pathogenesis of inﬂammatory and autoimmune
diseases, in human tear ﬂuid with matrix-assisted laserbranes Fung et al. (2004).
7 % of total Common proteins % of total
117
1.3 2 1.7
7.7 3 2.6
0.6 1 0.9
8.6 13 11.1
2.9 8 6.8
8.6 13 11.1
0.3 0 0.0
0.3 1 0.9
7.0 18 15.4
62.3 58 49.6
0.3 0 0.0
100.00 117 100.00
rent chromatogram of 10 SCX fractions received from a C. elegans
selected for fragmentation of 600 mM fraction at 34.5 min. (C)
eptides Husson et al. (2005).
Table 3 Identiﬁcation of C. elegans neuropeptides by 2D-nano-LC–MS/MS technique Husson et al. (2005).
Gene Gene similarity Peptides characterized by 2D-nano-LC–MS/MS
FMRFamide-related peptides or FaRPs
LRFamide family
ﬂp-1 C. vulgaris, C. briggsae SADPNFLRFamide
C. redivivus, myosuppressins AAADPNFLRFamide
ﬂp-18 C. briggsae EIPGVLRFamidea
SEVPGVLRFamide
SYFDEKKSVPGVLRFamide
SVPGVLRFamidea
DFDGAMPGVLRFamide
GAMPGVLRFamide
IRFamide family
ﬂp-5 C. briggsae GAKFIRFamide
ﬂp-13 C. briggsae APEASPFIRFamide
AMDSPLIRFamide
ASPSAPLIRFamidea
SPSAVPLIRFamide
SAAAPLIRFamide
AADGAPLIRFamide
MRFamide family
ﬂp-3 TPLGTMRFamide
EAEEPLGTMRFamide
SADDSAPFGTMRFamide
SAEPFGTMRFamide
ASEDALFGTMRFamide
NPENDTPFGTMRFamide
ﬂp-22 SPSAKWMRFamide
ﬂp-6 pQQDSEVEREMM
VRFamide family
ﬂp-9 C. briggsae KPSFVRFamide
ﬂp-11 C. briggsae ASGGMRNALVRFamide
NGAPQPFVRFamidea
SPLDEEDFAPESPLQamide
ﬂp-16 C. briggsae AQTFVRFamide
GQTFVRFamidea
ﬂp-19 C. briggsae WANQVRFamide
Neuropeptide-like protein (NLP) peptides
MSFamide family
nlp-1 C. briggsae, buccalin
drosulfakinin-0 MDANAFRMSFamide
VNLDPNSFRMSFamide
nlp-13 C. briggsae SAPSDFSRDIMSFamide
SSSMYDRDIMSFamidea
SPVDYDRPIMAFamide
nlp-7 C. briggsae LYLKQADFDDPRMFTSSFamidea
(F/M)G(L/F)amide family
nlp-6 C. briggsae, allatostatins A APKQMVFGFamide
GFxGF family
nlp-8 C. briggsae YPYLIFPASPSSGDSRRLV
C. briggsae SFDRMGGTEFGLM
nlp-14 C. briggsae, orcokinin ALNSLDGAGFGFE
nlp-15 C. briggsae AFDSLAGSGFDNGFN
FAFA family
nlp-18 C. briggsae SDEENLDFLE
SPYRTFAFA
SPYRAFAFA
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Table 3 (continued)
Gene Gene similarity Peptides characterized by 2D-nano-LC–MS/MS
GGARAF-family
nlp-21 C. briggsae pQYTSELEEDE
GGARVFQGFEDE
GGARAFLTEM
nlp-9 C. briggsae TPIAEAQGAPEDVDDRRELE
No multigene family
nlp-11 C. briggsae SPAISPAYQFENAFGLSEALERAamide
nlp-17 C. briggsae GSLSNMMRIamide
Newly characterized peptides
Novel FaRPs
ﬂp-24 C. briggsae VPSAGDMMVRFamide
VPSAGDM(ox)MVRFamide
VPSAGDMM(ox)VRFamide
VPSAGDM(ox)M(ox)VRFamide
ﬂp-26 C. briggsae EFNADDLTLRFamide
FNADDLTLRFamide
GGAGEPLAFSPDMLSLRFamide
Novel NLP peptides
nlp-35 C. briggsae AVVSGYDNIYQVLAPRF
nlp-36 C. briggsae SMVARQIPQTVVADH
nlp-37 C. briggsae NNAEVVNHILKNFGALDRLGDVamide
nlp-38/MIP Insect MIPs, B-type allatostatins TPQNWNKLNSLWamide
SPAQWQRANGLWamide
nlp-39 EVPNFQADNVPEAGGRV
nlp-40 C. briggsae APSAPAGLEEKL
APSAPAGLEEKLR
nlp-41 APGLFELPSRSV
a Peptides, which have Mowse scores below the threshold required for identity.
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lowed by size-exclusion high performance liquid chromatogra-
phy. The authors recognized some lacrimal-speciﬁc proteins.
The success of C. elegans (a nematode), genome project gave
a typical knowledge of neuropeptide signaling. Neuropeptide
are originated from proprotein peptide precursor genes.
Husson et al. (2005) performed a peptidomic analysis of
C. elegans using a strong cation exchange column (Bio-SCX,
500 lm · 15 mm) attached with a C18 pre-column and 2% ace-
tonitrile (ACN), 0.1% formic acid (FA) with water taking a
ﬂow rate of 30 lL/min. in a two-dimensional nano-scale liquid
chromatography-quadrupole time-of-ﬂight tandem-mass spec-
trometry (2D-nano-LC-Q-TOFMS/MS) method and reported
a total ion current (TIC) chromatogram for every nano-
LC–MS study shown in Fig. 7. The authors arranged 60
neuropeptides given in Table 3 and reported their similarity
with neuropeptides of vertebrates or invertebrates.
1.6. Capillary high performance liquid chromatography
A hybrid technique of HPLC and CE was developed in 1990
and is called as Capillary Electro-chromatography (CEC). It
is expected to combine high peak efﬁciency which is character-
istic of electrically driven separations with high separation
selectivity. CEC experiments can be carried out on wall coated
open tubular capillaries or capillaries packed with particulate
or monolithic silica or other inorganic materials as well as or-
ganic polymers. The chromatographic and electrophoreticmechanisms work simultaneously in CEC and several combi-
nations are possible.
The separation and identiﬁcation of some proteins was per-
formed in foam cells with capillary liquid chromatography fol-
lowed by mass spectrometry (Yang et al., 2007). Reinhardt and
Lippolis (2006) reported that out of 120 proteins, only 15 in
cow milk fat globule membranes (MFGM), had similarity with
previously studied mouse or human MFGM proteome using a
micro-capillary liquid chromatograph which was linked with a
nanospray-tandem-mass spectrometer. Casado et al. (2005)
identiﬁed 111 human nasal mucous proteins in nasal lavage
ﬂuids (NLFs) of ten volunteers (patients) using a capillary li-
quid chromatography-electrospray quadrupole-time-of-ﬂight
mass spectrometric method. Lominadze et al. (2005) analyzed
human neutrophil granules responsible for chemotaxis, phago-
cytosis and bacterial killing susing two-dimensional micro-
capillary chromatography, reversed phase micro-capillary
liquid chromatography followed by electrospray ionization
tandem-mass spectrometry (2D HPLC ESI-MS/MS) technique
and reported 286 proteins. Yuan and coworkers (Yuan and
Desiderio, 2005) studied low molecular mass peptides in
human cerebrospinal ﬂuid (CSF), i.e., amyloid-like protein 1,
secretogranin I, granin like neuroendocrine peptide precursor
and neurosecretory protein using capillary liquid chromatogra-
phy followed by quadrupole time-of-ﬂight mass spectrometry.
Boisvert et al. (2003) identiﬁed 200 novel arginine-methylated
proteins using micro-capillary liquid chromatography with
electrospray ionization tandem-mass spectrometry. Capillary
70 I. Ali et al.chromatography separation method was reported as a best
separation method in combination with mass spectrometry
for complex protein mixtures due to high sensitivity of this
method (Shen and Smith, 2002). Zhang et al. (2003) identiﬁed
145 unique peptides mapping 57 unique human serum proteins
using micro-capillary liquid chromatography electrospray ion-
ization MS/MS method. The nano-LC-FTICR analysis of
0.5 pg of a bacterium Deinococcus radiodurans proteome
was carried out using a 14.9 lm inner diameter separation cap-
illary that was packed with 3 lm diameter stationary phase
particles (Shen et al., 2004). Martinovic et al. (2000) reported
that capillary isoelectric focusing (CIEF) in combination with
FTICR-MS improved 10 throughputs for detection of pro-
teins. Zhang and coworkers (Zhang et al., 2007) reported
CEC of enriched peptides, i.e., nitrotyrosine-containing pep-
tides in complex proteome sample of mouse brain homoge-
nate. The mobile phases used were 0.2% acetic acid, and
0.05% TFA in water as solvent A and 0.1% TFA in 90% ace-
tonitrile as solvent B. Metz et al. (2006) used reversed-phase
capillary liquid chromatography for separation of vacuum
dried peptide fractions using reversed-phase capillary column
(65 cm · 150 lm) of fused silica capillary; packed with slurryTable 4 A comparison of proteomic analyses on various chromato
Proteomes Columns
Reversed phase high performance liquid chromatography
Complex protein mixture C18 column
Cycloskeletal proteins and enzymes PepMap C18 (250 mm · 0.3 mm)
Peptides of Caenorhabditis elegans C18 (250 mm · 4.6 mm i.d.)
S-transferase isoenzyme Vydac 214TP C4 (150 mm · 4.6 mm
Photosystem II antenna protein Vydac C4
Proteins of rat adipose cells Zorbax 300 SB-C3 (150 · 4.6 mm)
Complex protein mixture Zorbax SB-C18
GPI-APs protein Zorbax SB-C18
Phosphopeptides of rat kidney
IMCD
Picofrit RP column
Venoms of various snakes Lichrosphere RP100 C18
(250 · 4 mm with 5 lm)
Aﬃnity high performance liquid chromatography
Peptides of liver of mice Magic C18 AQ (75 lm · 15 cm)
Phosphopeptides of Arabidopsis PepMap C18 (300 lm · 5 mm)
Ligand exchange high performance liquid chromatography
Proteomic analysis of E. coli
strain BL 21
218 TP 5415 Vydac C18 RP column
(150 · 4.6 mm)
Pancreatic islet Proteome Polysulfoethyl A column (200 · 2.1
Membrane proteins of breast
cancer MCF7 and BT474 cells
Polysulfoethyl A resin (7.5 cm · 75
Peptidomic analysis of
Caenorhabditis elegans
Bio-SCX column (15 mm · 500 lm
Capillary electro-chromatography
Protein of Helicobacter pylori ReproSil-Pur C18-AQ (17 cm · 50 l
Tryptic peptide mixture of ﬁsh Phenomenex Jupiter C18 (250 · 2.1
Synaptic proteomes of wild
type mice
Polysulfoethyl A (150 mm · 100 lm
Proteomic analysis of E. coli
strain BL 21
TSKG3000SWxL (300 · 7 mm)
Vacuum dried peptides Jupiter C18 RP capillary column
(65 cm · 150)of 5.0 lm Jupiter C18-bonded particles. The mobile phases
were 0.2% acetic acid and 0.05% TFA in water (Solvent sys-
tem A) and 0.1% TFA in 90% acetonitrile in water (Solvent
system B) was achieved by MS/MS. Meek et al. (2004) re-
ported a descriptive proteomic analysis of interphase and mito-
tic 14-3-3-binding proteins using 14-3-3 zeta afﬁnity column
and many new 14-3-3 binding proteins were recognized by mi-
cro-capillary high performance liquid chromatography tan-
dem-mass spectrometry. These proteins had a signiﬁcant role
in cell cycle regulation, metabolism, protein synthesis, protein
folding, proteolysis, nucleic acid binding etc.1.7. Comparison of various chromatographic methods
Among various chromatographic methods used in proteomic
analyses the order of application is reversed phase > gel per-
meation > ligand exchange > afﬁnity. During our search of
literature it was found that the maximum papers on proteomic
analyses were on reversed phase high performance liquid chro-
matography. It is due the fact that this kind of chromatogra-
phy is well developed. There are many types of reversedgraphic techniques.
Mobile phases References
Acetonitrile–TFA Wang et al. (2005)
– Babusiak et al. (2007)
Acetonitrile–formic acid Husson et al. (2006)
) Acetonitrile and water with TFA Gallagher et al. (2006)
Acetonitrile–water–TFA Zolla et al. (2003)
Acetonitrile–TFA Chen et al. (2005)
Buﬀer–acetonitrile–FA Bihan et al. (2004)
Buﬀer–acetonitrile–TFA
Acetonitrile with acids HFBA
(diﬀerent combinations)
Elortza et al. (2006)
Acetonitrile–FA Hoﬀert et al. (2007)
Water–acetonitrile–TFA Calvete et al. (2007)
Water–acetonitrile–FA Welch et al. (2005)
– de la Fuente van
Bentem et al. (2006)
Acetonitrile–water–TFA Lecchi et al. (2003)
mm) 10 mM Ammonium formate
buﬀer–water and acetonitrile
Metz et al. (2006)
lm i.d.) – Xiang et al. (2004)
) Water–acetonitrile–FA Husson et al. (2005)
m i.d.) – Carlsohn et al. (2006)
nm) Acetonitrile–TFA–formic acid Monti et al. (2005)
i.d.) Buﬀers–acetonitrile–10 mM
KH2PO4
Li et al. (2007)
Water–50 mM KH2PO4–200 nM
NaCl
Lecchi et al. (2003)
Water with TFA and FA, water
and acetonitrile with TFA
Metz et al. (2006)
Separation of biological proteins by liquid chromatography 71phase stationary phases available, which can be used for anal-
yses of proteomes. Besides, the reversed phase columns are
capable to work with a wide range of mobile phases, enhancing
the application range of reversed phase chromatography. On
the other hand, gel permeation HPLC is also useful for proteo-
mic separation and identiﬁcation due to a wide variation in the
sizes of proteins. Ligand exchange is also useful as proteins
have charges, which may be exploited in this kind of chroma-
tography. Afﬁnity and capillary electro-chromatographic tech-
niques have also been used in proteomic area. Later technique
is more useful as it needs little amount of sample and also has
low detection limit. Therefore, all these techniques are impor-
tant and useful for proteomics analyses depending on the type
and nature of the proteins to be analyzed. They have their own
merits and demerits, which cannot be discussed in detail here.
However, the comparative features can be seen from Table 4
having applications of different kinds of chromatographic
methods.
1.8. Chirality and chirality and protomics
It is well known-fact that millions of our bodies proteins inter-
act among themselves and with the biological environment,
i.e., with cell, tissue, organelle, protoplasm and other cellular
molecules. Normally, these interactions are ideal at the time
of birth but may change into abnormal during the course of
time resulting into various diseases. The proteomics is more
difﬁcult phase in the process of understanding cellular bio-
chemistry and mechanisms of disease. It is very important to
mention here that proteomic interactions are stereospeciﬁc in
nature (Kawamura and Hindi, 2005). These interactions deﬁne
an individual’s state of wellness or disease. Perhaps, the abnor-
mal interactions of proteins occur due to change in the chiral
structure of proteins. Therefore, the main root of diseases at
molecular level could be due to chiral based abnormal interac-
tions. The understanding of the mechanisms of chiral change
in proteins and their interactions may be boon to control var-
ious diseases.
Of course, it is very complicated issue to ascertain the mech-
anisms of diseases through proteomics and to the best of our
knowledge there is no report available on this subject. Visual-
ization has been made for proteomes interactions and tried to
establish the mechanisms of diseases evolution. Under normal
situations the proteins are synthesized in cell by the direction
of genomes and they interact into the body for some fruitful
purposes, i.e., growth and repair of the body. But under abnor-
mal conditions some mutation occurred into genome resulting
into deformated protein synthesis, which results into major or
small change into their chiral structures. Due to change in chi-
ral structures of proteins their mode of interactions is changed
slightly giving rise abnormal behavior of cell and organs, i.e.,
diseases. For example the carcinoma is nothing but abnormal
growth of cells. As stated above that various interactions of
proteins may be reﬂected into an individual’s state of wellness
or disease. For example, a speciﬁc conﬁguration of proteins in
liver tissue could deﬁne a particular tumor.
2. Conclusion
Liquid chromatography is considered to be the back bone of
the separation science. With the hyphenation of mass spec-trometer detectors this technique has achieved heights in
analysis work. It can detect molecules at the level of the
nanomole. Hence, it is useful in proteomics and genome re-
search. Many kinds of liquid chromatography such as re-
versed phase high performance liquid chromatography,
afﬁnity high performance liquid chromatography, gel perme-
ation high performance liquid chromatography, ligand ex-
change high performance liquid chromatography and
capillary high performance liquid chromatography have been
used in proteomic research. More advance paraphernalia is
required to achieve the detection at picomolar and femtomo-
lar levels, which are required in proteomics and genome re-
search. Besides, the mechanism and medication of various
diseases can be understood by using the concept of chirality
in proteomic. Chiral chromatography may be a useful tool
for the proteomic interactions.Acknowledgements
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